Section Arrow
Quote
SBFM.NASDAQ
- Sunshine Biopharma Inc.
Quotes are at least 15-min delayed:2026/07/05 22:12 EDT
Regular Hours
Last
 2.11
-0.07 (-3.21%)
Day High 
2.2 
Prev. Close
2.18 
1-M High
3.05 
Volume 
51.13K 
Bid
2.1
Ask
2.12
Day Low
2.1 
Open
2.15 
1-M Low
2 
Market Cap 
4.63M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.11 
20-SMA 2.23 
50-SMA 5.29 
52-W High 24.3 
52-W Low 2 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-12.50/--
Enterprise Value
5.23M
Balance Sheet
Book Value Per Share
10.13
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
36.31M
Operating Revenue Per Share
6.84
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health36.8-0.77-2.05%-- 
CGCCanopy Growth Corp1+0.0513+5.41%-- 
HLNHaleon plc9.82+0.42+4.47%19.13PE
VTRSViatris16.7+0.52+3.21%-- 
ESPREsperion Therapeutics3.16------ 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.